DE3751524T2
(de)
|
1986-07-28 |
1996-06-13 |
American Cyanamid Co |
5(und/oder6) Substituierte 2-(2-Imidazolin-2-yl)nicotinsäuren, Ester und Salze, verwendbar als herbizide Mittel und Zwischenverbindungen für die Herstellung dieser Nikotinsäuren, Ester und Salze.
|
FR2624698A1
(fr)
|
1987-12-18 |
1989-06-23 |
Bernard Lyon I Universite Clau |
Derives heterocycliques de n-carbamoyl-, n-thiocarbamoyl- ou n-amidino-aminomalonyl ou aminosuccinyl amides utiles comme agents edulcorants
|
JPH04503672A
(ja)
|
1989-02-27 |
1992-07-02 |
イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー |
放射線増感剤としての新規なナフタレンスルホンアミド
|
US5776963A
(en)
|
1989-05-19 |
1998-07-07 |
Hoechst Marion Roussel, Inc. |
3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
|
GB8927872D0
(en)
|
1989-12-08 |
1990-02-14 |
Beecham Group Plc |
Pharmaceuticals
|
JP2807577B2
(ja)
|
1990-06-15 |
1998-10-08 |
エーザイ株式会社 |
環状アミド誘導体
|
DE4121214A1
(de)
|
1991-06-27 |
1993-01-14 |
Bayer Ag |
7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
|
EP0520573A1
(en)
|
1991-06-27 |
1992-12-30 |
Glaxo Inc. |
Cyclic imide derivatives
|
US5416099A
(en)
|
1991-10-29 |
1995-05-16 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
US5272158A
(en)
|
1991-10-29 |
1993-12-21 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
US5389631A
(en)
|
1991-10-29 |
1995-02-14 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
US5238950A
(en)
|
1991-12-17 |
1993-08-24 |
Schering Corporation |
Inhibitors of platelet-derived growth factor
|
US5364869A
(en)
|
1992-03-09 |
1994-11-15 |
Abbott Laboratories |
Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists
|
US5326760A
(en)
|
1992-06-29 |
1994-07-05 |
Glaxo, Inc. |
Aminobutanoic acid compounds having metalloprotease inhibiting properties
|
JPH06236056A
(ja)
|
1993-02-10 |
1994-08-23 |
Fuji Xerox Co Ltd |
電子写真感光体
|
JP3760474B2
(ja)
|
1993-04-22 |
2006-03-29 |
ダイキン工業株式会社 |
電気エネルギーを発生させる方法、装置およびそれに用いるn−f結合を有する化合物
|
CA2134192A1
(en)
|
1993-11-12 |
1995-05-13 |
Michael L. Denney |
5, 6-bicyclic glycoprotein iib/iiia antagonists
|
DE4343922A1
(de)
|
1993-12-22 |
1995-06-29 |
Basf Ag |
Pyridin-2,3-dicarbonsäureimide, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung unerwünschten Pflanzenwuchses
|
KR970007419B1
(ko)
|
1993-12-30 |
1997-05-08 |
한솔제지 주식회사 |
승화형 열전사 기록용 색소
|
FR2725946A1
(fr)
|
1994-10-24 |
1996-04-26 |
Lohr Ind |
Cale a rapporter sur un plan porteur presentant des perforations
|
US5719144A
(en)
|
1995-02-22 |
1998-02-17 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
US5770590A
(en)
|
1995-03-24 |
1998-06-23 |
Takeda Chemical Industries, Ltd. |
Cyclic compounds, their prudiction and use
|
EP0733632B1
(en)
|
1995-03-24 |
2003-06-04 |
Takeda Chemical Industries, Ltd. |
Cyclic compounds, their production and use as tachykinin receptor antagonists
|
WO1997024334A1
(fr)
|
1995-12-28 |
1997-07-10 |
Fujisawa Pharmaceutical Co., Ltd. |
Derives du benzimidazole
|
DE19608791A1
(de)
|
1996-03-07 |
1997-09-11 |
Hoechst Ag |
Verfahren zur Herstellung von fluorierten Aromaten und fluorierten stickstoffhaltigen Heteroaromaten
|
DE19702282C2
(de)
|
1997-01-23 |
1998-11-19 |
Hoechst Ag |
Katalysator für Halex-Reaktionen
|
WO1998040385A1
(en)
|
1997-03-07 |
1998-09-17 |
Novo Nordisk A/S |
4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
|
US6177443B1
(en)
|
1997-03-07 |
2001-01-23 |
Novo Nordisk A/S |
4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
|
KR19980074060A
(ko)
|
1997-03-21 |
1998-11-05 |
김윤배 |
신규한 치환된 3,4-디알콕시페닐 유도체
|
JPH1143489A
(ja)
|
1997-05-30 |
1999-02-16 |
Takeda Chem Ind Ltd |
ヘテロ環化合物、その製造法および剤
|
KR20010041991A
(ko)
|
1998-03-19 |
2001-05-25 |
다케다 야쿠힌 고교 가부시키가이샤 |
복소환식 화합물, 그의 제조법 및 타키키닌 수용체길항약으로서의 용도
|
US20020132817A1
(en)
|
1998-03-19 |
2002-09-19 |
Hideaki Natsugari |
Heterocyclic compounds, their production and use
|
FR2778662B1
(fr)
|
1998-05-12 |
2000-06-16 |
Adir |
Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
JP2000007661A
(ja)
|
1998-06-23 |
2000-01-11 |
Nippon Nohyaku Co Ltd |
複素環ジカルボン酸ジアミド誘導体及びその中間体並びに除草剤
|
BR9912571A
(pt)
|
1998-07-28 |
2001-11-20 |
Nihon Nohyaku Co Ltd |
Derivado de diamida de ácido dicarboxìlicoheterocìclico fundido, herbicida, e, processo paraa utilização de um herbicida
|
US6348032B1
(en)
|
1998-11-23 |
2002-02-19 |
Cell Pathways, Inc. |
Method of inhibiting neoplastic cells with benzimidazole derivatives
|
AU1409100A
(en)
|
1998-11-27 |
2000-06-19 |
Takeda Chemical Industries Ltd. |
Drugs
|
WO2000067754A1
(en)
|
1999-05-12 |
2000-11-16 |
Nitromed, Inc. |
Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
|
RS50340B
(sr)
|
1999-06-23 |
2009-11-10 |
Sanofi-Aventis Deutschland Gmbh., |
Supstituisani benzimidazoli
|
RU2002104496A
(ru)
|
1999-07-21 |
2003-09-27 |
Астразенека Аб (Se) |
Новые соединения
|
JP3961827B2
(ja)
*
|
1999-08-02 |
2007-08-22 |
エフ.ホフマン−ラ ロシュ アーゲー |
新規な選択的レチノイドアゴニスト
|
ATE402937T1
(de)
|
1999-11-09 |
2008-08-15 |
Abbott Lab |
Hydromorphinone and hydrocodeinone compositions and methods for their synthesis
|
US6770666B2
(en)
|
1999-12-27 |
2004-08-03 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs
|
ID30204A
(id)
|
1999-12-27 |
2001-11-15 |
Japan Tobacco Inc |
Senyawa-senyawa cincin terfusi dan penggunaannya sebagai obat
|
DE19963177A1
(de)
|
1999-12-27 |
2001-07-12 |
Gruenenthal Gmbh |
Substanzbibliothek
|
WO2001051128A1
(en)
|
2000-01-12 |
2001-07-19 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
CA2377629A1
(en)
|
2000-04-25 |
2001-11-08 |
Hae-Young Bae |
Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
|
KR100608405B1
(ko)
|
2000-05-02 |
2006-08-02 |
에프. 호프만-라 로슈 아게 |
신규한 감마 선택적인 레티노이드
|
CA2408156A1
(en)
|
2000-05-05 |
2001-11-15 |
Millennium Pharmaceuticals, Inc. |
Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
|
US6552015B2
(en)
|
2000-08-03 |
2003-04-22 |
Pfizer Inc. |
Azabicycloalkane derivatives and therapeutic uses thereof
|
WO2002024650A2
(en)
|
2000-09-19 |
2002-03-28 |
Centre National De La Recherche Scientifique (Cnrs) |
Pyridinone and pyridinethione derivatives having hiv inhibiting properties
|
US6884782B2
(en)
|
2000-11-08 |
2005-04-26 |
Amgen Inc. |
STAT modulators
|
US6677365B2
(en)
|
2001-04-03 |
2004-01-13 |
Telik, Inc. |
Antagonists of MCP-1 function and methods of use thereof
|
WO2002081447A1
(en)
|
2001-04-06 |
2002-10-17 |
Daewoong Pharmaceutical Co., Ltd. |
3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof
|
US7456183B2
(en)
|
2001-04-09 |
2008-11-25 |
Novartis Vaccines And Diagnostics, Inc. |
Guanidino compounds
|
MXPA03009497A
(es)
|
2001-04-19 |
2004-05-24 |
Eisai Co Ltd |
Derivados de 2-iminopirrolidina.
|
DE60221392T2
(de)
|
2001-05-24 |
2008-04-17 |
Eli Lilly And Co., Indianapolis |
Neue pyrrolderivate als pharmazeutische mittel
|
US6987187B2
(en)
|
2001-07-16 |
2006-01-17 |
Shionogi & Co., Ltd. |
Process for preparation of amidine derivatives
|
US6627646B2
(en)
|
2001-07-17 |
2003-09-30 |
Sepracor Inc. |
Norastemizole polymorphs
|
WO2003029254A1
(fr)
|
2001-09-28 |
2003-04-10 |
Takeda Chemical Industries, Ltd. |
Procede de preparation de composes tricycliques
|
JP2003171380A
(ja)
|
2001-09-28 |
2003-06-20 |
Takeda Chem Ind Ltd |
三環性化合物の製造法
|
CA2462453C
(en)
|
2001-10-02 |
2009-07-28 |
Pharmacia & Upjohn Company |
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
|
DE10156719A1
(de)
|
2001-11-19 |
2003-05-28 |
Bayer Ag |
Heteroarylcarbonsäureamide
|
TWI263640B
(en)
|
2001-12-19 |
2006-10-11 |
Bristol Myers Squibb Co |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
|
KR100659428B1
(ko)
|
2002-02-04 |
2006-12-19 |
에프. 호프만-라 로슈 아게 |
Npy 길항제로서의 퀴놀린 유도체
|
DE10207037A1
(de)
|
2002-02-20 |
2003-08-28 |
Bayer Cropscience Gmbh |
2-Amino-4-bicyclyamino-6H-1,3.5-triazine, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
WO2003076440A1
(en)
|
2002-03-06 |
2003-09-18 |
Smithkline Beecham Corporation |
Condensed heterocyclic compounds as calcitonin agonists
|
WO2003104216A1
(en)
|
2002-06-10 |
2003-12-18 |
Acadia Pharmaceuticals Inc. |
Urotensin ii receptor modulators
|
WO2004014365A1
(en)
*
|
2002-08-13 |
2004-02-19 |
Warner-Lambert Company Llc |
Phthalimide derivatives as matrix metalloproteinase inhibitors
|
US7365066B2
(en)
|
2002-09-17 |
2008-04-29 |
Eli Lilly And Company |
Pyrazolopyridine derivatives as pharmaceutical agents
|
WO2004044132A2
(en)
|
2002-11-05 |
2004-05-27 |
Isis Pharmaceuticals, Inc. |
Modified oligonucleotides for use in rna interference
|
JP2004203791A
(ja)
|
2002-12-25 |
2004-07-22 |
Dai Ichi Seiyaku Co Ltd |
芳香族化合物
|
CN1212674C
(zh)
|
2003-01-08 |
2005-07-27 |
东南大学 |
横向缓冲p型金属氧化物半导体管
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
GB0308025D0
(en)
|
2003-04-07 |
2003-05-14 |
Glaxo Group Ltd |
Compounds
|
MY150088A
(en)
|
2003-05-19 |
2013-11-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
US7060697B2
(en)
|
2003-05-19 |
2006-06-13 |
Irm Llc |
Immunosuppressant compounds and compositions
|
CL2004001120A1
(es)
|
2003-05-19 |
2005-04-15 |
Irm Llc |
Compuestos derivados de amina sustituidas con heterociclos, inmunosupresores; composicion farmaceutica; y uso para tratar enfermedades mediadas por interacciones de linfocito, tales como enfermedades autoinmunes, inflamatorias, infecciosas, cancer.
|
JP4728962B2
(ja)
|
2003-05-19 |
2011-07-20 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
免疫抑制化合物および組成物
|
US20050004133A1
(en)
|
2003-06-05 |
2005-01-06 |
Makings Lewis R. |
Modulators of VR1 receptor
|
CN1566099A
(zh)
|
2003-06-13 |
2005-01-19 |
中国科学院上海药物研究所 |
异喹啉-1,3,4-三酮类化合物、制备方法及其用途
|
WO2005005392A1
(en)
|
2003-07-07 |
2005-01-20 |
Ionix Pharmaceuticals Limited |
Azacyclic compounds as inhibitors of sensory neurone specific channels
|
FR2857966A1
(fr)
|
2003-07-24 |
2005-01-28 |
Aventis Pharma Sa |
Produits aryl-heteroaromatiques, compositions les contenant et utilisation
|
MXPA06001320A
(es)
|
2003-08-01 |
2006-05-04 |
Pfizer Prod Inc |
Compuestos heteroarilo de 6 miembros para el tratamiento de trastornos neurodegenerativos.
|
EP1675858A2
(en)
|
2003-09-03 |
2006-07-05 |
Neurogen Corporation |
5-aryl-pyrazolo [4,3-d] pyrimidines, pyridines, and pyrazines and related compounds
|
US20050113379A1
(en)
|
2003-09-05 |
2005-05-26 |
Ping Ge |
Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligands
|
US20070088163A1
(en)
|
2003-09-12 |
2007-04-19 |
Kemia, Inc. |
Modulators of calcitonin and amylin activity
|
US20050182061A1
(en)
|
2003-10-02 |
2005-08-18 |
Jeremy Green |
Phthalimide compounds useful as protein kinase inhibitors
|
US7772234B2
(en)
|
2003-11-19 |
2010-08-10 |
Array Biopharma Inc. |
Bicyclic inhibitors of MEK and methods of use thereof
|
US7732616B2
(en)
|
2003-11-19 |
2010-06-08 |
Array Biopharma Inc. |
Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
|
US20050203151A1
(en)
|
2003-12-19 |
2005-09-15 |
Kalypsys, Inc. |
Novel compounds, compositions and uses thereof for treatment of metabolic disorders and related conditions
|
JP2007516275A
(ja)
|
2003-12-23 |
2007-06-21 |
ファイザー・プロダクツ・インク |
認知増強および精神病性障害のための治療的組合せ
|
US7608627B2
(en)
|
2004-04-05 |
2009-10-27 |
Takeda Pharmaceutical Company Limited |
6-azaindole compound
|
WO2005100334A1
(en)
|
2004-04-14 |
2005-10-27 |
Pfizer Products Inc. |
Dipeptidyl peptidase-iv inhibitors
|
GB0412467D0
(en)
|
2004-06-04 |
2004-07-07 |
Astrazeneca Ab |
Chemical compounds
|
SG155941A1
(en)
|
2004-09-22 |
2009-10-29 |
Janssen Pharmaceutica Nv |
Inhibitors of the interaction between mdm2 and p53
|
US20060128710A1
(en)
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
WO2006065842A2
(en)
|
2004-12-13 |
2006-06-22 |
Synta Pharmaceuticals Corp. |
5,6,7,8-tetrahydroquinolines and related compounds and uses thereof
|
EP1838320B1
(en)
|
2005-01-07 |
2014-07-16 |
Emory University |
Cxcr4 antagonists for the treatment of medical disorders
|
EP1848694B1
(en)
|
2005-02-07 |
2009-11-25 |
F. Hoffmann-Roche AG |
Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
|
GB0504556D0
(en)
|
2005-03-04 |
2005-04-13 |
Pfizer Ltd |
Novel pharmaceuticals
|
WO2006109085A1
(en)
|
2005-04-13 |
2006-10-19 |
Astex Therapeutics Limited |
Hydroxybenzamide derivatives and their use as inhibitors of hsp90
|
WO2007050124A1
(en)
|
2005-05-19 |
2007-05-03 |
Xenon Pharmaceuticals Inc. |
Fused piperidine derivatives and their uses as therapeutic agents
|
WO2007007054A1
(en)
|
2005-07-08 |
2007-01-18 |
Cancer Research Technology Limited |
Phthalamides, succinimides and related compounds and their use as pharmaceuticals
|
MX2008002207A
(es)
|
2005-08-16 |
2008-03-27 |
Memory Pharm Corp |
Inhibidores de fosfodiesterasa 10.
|
WO2007036733A1
(en)
|
2005-09-29 |
2007-04-05 |
Glaxo Group Limited |
Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
|
EP1953165B1
(en)
|
2005-11-10 |
2012-02-01 |
Msd K.K. |
Aza-substituted spiro derivative
|
AR059036A1
(es)
|
2006-01-17 |
2008-03-12 |
Schering Corp |
Compuestos para el tratamiento de trastornos inflamatorios
|
WO2007084815A2
(en)
|
2006-01-19 |
2007-07-26 |
Janssen Pharmaceutica, N.V. |
Substituted thienopyrimidine kinase inhibitors
|
US7750034B2
(en)
|
2006-01-25 |
2010-07-06 |
Merck Sharp & Dohme Corp. |
Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
AU2007218053B2
(en)
|
2006-02-15 |
2010-05-27 |
Merck Sharp & Dohme Corp. |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
WO2007101225A2
(en)
|
2006-02-27 |
2007-09-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods to identify inhibitors of the unfolded protein response
|
AU2007228784B2
(en)
|
2006-03-22 |
2012-03-08 |
Janssen Pharmaceutica N.V. |
Cyclic-alkylaminederivatives as inhibitors of the interaction between MDM2 and p53
|
US7977351B2
(en)
|
2006-03-22 |
2011-07-12 |
Allergan, Inc. |
Heteroaryl dihydroindolones as kinase inhibitors
|
MX2008013530A
(es)
*
|
2006-04-20 |
2009-01-14 |
Janssen Pharmaceutica Nv |
Inhibidores de c-fms cinasa.
|
WO2008118122A2
(en)
|
2006-05-08 |
2008-10-02 |
Molecular Neuroimaging, Llc |
Compounds and amyloid probes thereof for therapeutic and imaging uses
|
PL2051975T3
(pl)
|
2006-05-16 |
2013-01-31 |
Boehringer Ingelheim Int |
Podstawione prolinamidy, ich wytwarzanie oraz ich zastosowanie jako środków leczniczych
|
CN1869036A
(zh)
|
2006-06-30 |
2006-11-29 |
中国药科大学 |
7-取代-3-氯吡咯并[3,4-b]吡啶化合物
|
DE102006032824A1
(de)
|
2006-07-14 |
2008-01-17 |
Bayer Healthcare Ag |
Substituierte Indazole
|
AU2007275816A1
(en)
|
2006-07-17 |
2008-01-24 |
Merck Sharp & Dohme Corp. |
1-hydroxy naphthyridine compounds as anti-HIV agents
|
EP2051964A4
(en)
|
2006-07-28 |
2012-03-07 |
Univ Connecticut |
FATTY ACID HYDROLASE AMIDE INHIBITORS
|
US8389739B1
(en)
|
2006-10-05 |
2013-03-05 |
Orphagen Pharmaceuticals |
Modulators of retinoid-related orphan receptor gamma
|
WO2008044029A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
WO2008044054A2
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Hydroxy-substituted benzoic acid amide compounds for use in therapy
|
US8916552B2
(en)
|
2006-10-12 |
2014-12-23 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
WO2008044027A2
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical compounds having hsp90 inhibitory or modulating activity
|
WO2008044045A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
PE20080888A1
(es)
|
2006-10-18 |
2008-08-26 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE LA ACIL-TRANSFERASA DE ACIL-CoA-DIACIL-GLICEROL 1 (DGAT1)
|
BRPI0720023A2
(pt)
|
2006-12-11 |
2018-09-04 |
Novartis Ag |
método para prevenir ou tratar isquemia do miocárdio por inibição da enzima dgat1 com um inibidor de dgat1
|
WO2008083070A1
(en)
|
2006-12-29 |
2008-07-10 |
Neurogen Corporation |
Crf1 receptor ligands comprising fused bicyclic heteroaryl moieties
|
CA2679563A1
(en)
|
2007-01-08 |
2008-07-17 |
Phenomix Corporation |
Macrocyclic hepatitis c protease inhibitors
|
WO2009004496A2
(en)
|
2007-04-13 |
2009-01-08 |
University Of Manitoba |
Bisanthrapyrazoles as anti-cancer agents
|
US20110189167A1
(en)
|
2007-04-20 |
2011-08-04 |
Flynn Daniel L |
Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
|
US20100129933A1
(en)
|
2007-04-26 |
2010-05-27 |
Forschungszentrum Karlsruhe Gmbh |
Method for detecting the binding between mdm2 and the proteasome
|
WO2008135524A2
(en)
|
2007-05-02 |
2008-11-13 |
Boehringer Ingelheim International Gmbh |
Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
|
TW200902533A
(en)
|
2007-05-02 |
2009-01-16 |
Boehringer Ingelheim Int |
Carboxylic acid amides, manufacturing and use thereof as medicaments
|
EP2152794B1
(en)
|
2007-05-10 |
2014-01-08 |
Constar International LLC |
Oxygen scavenging molecules, articles containing same, and methods of their use
|
TW200902499A
(en)
|
2007-05-15 |
2009-01-16 |
Astrazeneca Ab |
New compounds
|
GB0710844D0
(en)
|
2007-06-06 |
2007-07-18 |
Lectus Therapeutics Ltd |
Potassium ion channel modulators & uses thereof
|
DE102007034620A1
(de)
|
2007-07-25 |
2009-01-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue B1-Antagonisten
|
WO2009026248A2
(en)
|
2007-08-17 |
2009-02-26 |
The Government Of The United States, As Represented By The Secretary Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer |
Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase
|
NZ584720A
(en)
|
2007-09-17 |
2012-07-27 |
Abbott Lab |
Uracil or thymine derivative for treating hepatitis c
|
US20090076275A1
(en)
|
2007-09-19 |
2009-03-19 |
David Robert Bolin |
Diacylglycerol acyltransferase inhibitors
|
EP2217068A4
(en)
|
2007-10-11 |
2011-09-14 |
Glaxosmithkline Llc |
NOVEL INHIBITORS OF SEH AND THEIR USE
|
CA2702946A1
(en)
|
2007-10-16 |
2009-04-23 |
Northeastern University |
Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity
|
JP2011500635A
(ja)
|
2007-10-18 |
2011-01-06 |
ノバルティス アーゲー |
癌および骨疾患の処置のためのcsf−1r阻害剤
|
BRPI0821102A2
(pt)
|
2007-11-29 |
2015-06-16 |
Hoffmann La Roche |
Preparação de derivados de di-hidropirrol como intermediários
|
WO2009073788A1
(en)
|
2007-12-07 |
2009-06-11 |
Firestone Leigh H |
Compositions and methods for treating menopausal females
|
EP2078711A1
(en)
|
2007-12-28 |
2009-07-15 |
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. |
(Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
|
GB0800035D0
(en)
|
2008-01-02 |
2008-02-13 |
Glaxo Group Ltd |
Compounds
|
FR2926554B1
(fr)
|
2008-01-22 |
2010-03-12 |
Sanofi Aventis |
Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique
|
CN101225070B
(zh)
|
2008-01-31 |
2010-04-14 |
上海交通大学 |
用于抗肿瘤的药物
|
JP2011511018A
(ja)
|
2008-02-05 |
2011-04-07 |
サノフィ−アベンティス |
Par1阻害剤としてのsf5誘導体、その製造、及び薬剤としての使用
|
WO2009112445A1
(en)
|
2008-03-10 |
2009-09-17 |
Novartis Ag |
Method of increasing cellular phosphatidyl choline by dgat1 inhibition
|
GB0804702D0
(en)
|
2008-03-13 |
2008-04-16 |
Amura Therapeutics Ltd |
Compounds
|
GB0804701D0
(en)
|
2008-03-13 |
2008-04-16 |
Amura Therapeutics Ltd |
Compounds
|
WO2009124755A1
(en)
|
2008-04-08 |
2009-10-15 |
European Molecular Biology Laboratory (Embl) |
Compounds with novel medical uses and method of identifying such compounds
|
US7863291B2
(en)
|
2008-04-23 |
2011-01-04 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
US8309577B2
(en)
|
2008-04-23 |
2012-11-13 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
|
GB0809776D0
(en)
|
2008-05-29 |
2008-07-09 |
Amura Therapeutics Ltd |
Compounds
|
JP5615274B2
(ja)
|
2008-07-01 |
2014-10-29 |
ジェネンテック, インコーポレイテッド |
Mekキナーゼインヒビターとしてのイソインドロン誘導体及びその使用方法
|
EP2331499B1
(en)
|
2008-08-19 |
2016-09-21 |
Janssen Pharmaceutica NV |
Cold menthol receptor antagonists
|
US20110230472A1
(en)
|
2008-08-29 |
2011-09-22 |
Shionogi & Co., Ltd. |
Ring-fused azole derivative having pi3k-inhibiting activity
|
CA2741400A1
(en)
|
2008-09-16 |
2010-03-25 |
Merck & Co., Inc. |
Sulfonamide derivative metabotropic glutamate r4 ligands
|
WO2010056195A1
(en)
|
2008-11-14 |
2010-05-20 |
Astrazeneca Ab |
New compounds 575
|
US20100125081A1
(en)
|
2008-11-14 |
2010-05-20 |
Astrazeneca Ab |
New compounds 574
|
CN101455661B
(zh)
|
2008-11-19 |
2012-10-10 |
中国科学院上海有机化学研究所 |
3-取代苯酞及其类似物的用途
|
RU2016116516A
(ru)
|
2008-12-08 |
2018-12-07 |
Мандифарма Интернэшнл Корпорейшн Лимитед |
Композиции ингибиторов тирозинкиназных рецепторов белков
|
PT2391608E
(pt)
|
2009-01-28 |
2013-05-13 |
Bayer Cropscience Ag |
Derivados de n-cicloalquil-n-biciclíco-metilenocarboxamida fungicidas
|
WO2011078143A1
(ja)
|
2009-12-22 |
2011-06-30 |
塩野義製薬株式会社 |
ピリミジン誘導体およびそれらを含有する医薬組成物
|
JP2013517326A
(ja)
|
2010-01-19 |
2013-05-16 |
リサーチ・トライアングル・インスティチュート |
κオピオイド受容体結合リガンド
|
EP2528911B1
(en)
|
2010-01-28 |
2017-10-25 |
President and Fellows of Harvard College |
Compositions and methods for enhancing proteasome activity
|
EP2368886A1
(en)
|
2010-03-01 |
2011-09-28 |
Phenex Pharmaceuticals AG |
Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease
|
CN102241621A
(zh)
|
2010-05-11 |
2011-11-16 |
江苏恒瑞医药股份有限公司 |
5,5-双取代-2-亚氨基吡咯烷类衍生物、其制备方法及其在医药上的应用
|
US8980929B2
(en)
|
2010-05-21 |
2015-03-17 |
Merck Sharp & Dohme Corp. |
Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
|
DK2582674T3
(da)
|
2010-06-16 |
2014-12-15 |
Cymabay Therapeutics Inc |
GPR120-receptoragonister og anvendelser deraf.
|
US8299117B2
(en)
|
2010-06-16 |
2012-10-30 |
Metabolex Inc. |
GPR120 receptor agonists and uses thereof
|
WO2012027965A1
(en)
|
2010-09-01 |
2012-03-08 |
Glaxo Group Limited |
Novel compounds
|
WO2012028100A1
(en)
|
2010-09-01 |
2012-03-08 |
Glaxo Group Limited |
Novel compounds
|
AU2011295725B2
(en)
|
2010-09-03 |
2015-03-26 |
Forma Tm, Llc. |
Novel compounds and compositions for the inhibition of NAMPT
|
EP2621914B1
(en)
|
2010-09-27 |
2016-12-28 |
Abbott GmbH & Co. KG |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
JP2013253019A
(ja)
|
2010-09-28 |
2013-12-19 |
Kowa Co |
新規なピペリジン誘導体及びこれを含有する医薬
|
US9512111B2
(en)
|
2010-11-08 |
2016-12-06 |
Lycera Corporation |
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
|
EP2638034A1
(en)
|
2010-11-10 |
2013-09-18 |
Grünenthal GmbH |
Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
|
WO2012100732A1
(en)
|
2011-01-24 |
2012-08-02 |
Glaxo Group Limited |
Retinoid-related orphan receptor gamma modulators, composition containing them and uses thereof
|
WO2012100734A1
(en)
|
2011-01-24 |
2012-08-02 |
Glaxo Group Limited |
Compounds useful as retinoid-related orphan receptor gamma modulators
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
CN102180780A
(zh)
|
2011-03-07 |
2011-09-14 |
中国科学技术大学 |
茚酮类衍生物及其作为淀粉样蛋白沉积物和神经纤维缠结的显像剂和聚集抑制剂的用途
|
WO2012125521A1
(en)
|
2011-03-14 |
2012-09-20 |
Eternity Bioscience Inc. |
Quinazolinediones and their use
|
CN103635458B
(zh)
|
2011-03-25 |
2016-10-19 |
艾伯维公司 |
Trpv1拮抗剂
|
KR101926892B1
(ko)
|
2011-04-04 |
2018-12-07 |
메르크 파텐트 게엠베하 |
금속 착물
|
EP2511263A1
(en)
|
2011-04-14 |
2012-10-17 |
Phenex Pharmaceuticals AG |
Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
|
AR086156A1
(es)
|
2011-04-28 |
2013-11-20 |
Japan Tobacco Inc |
Compuesto de amida y su uso medicinal
|
US9938269B2
(en)
|
2011-06-30 |
2018-04-10 |
Abbvie Inc. |
Inhibitor compounds of phosphodiesterase type 10A
|
WO2013019621A1
(en)
|
2011-07-29 |
2013-02-07 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
EP2747560A4
(en)
|
2011-07-29 |
2015-02-25 |
Tempero Pharmaceuticals Inc |
CONNECTIONS AND METHODS
|
EP2738170B1
(en)
|
2011-07-29 |
2017-08-30 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
EP2736332A4
(en)
|
2011-07-29 |
2015-03-18 |
Tempero Pharmaceuticals Inc |
CONNECTIONS AND METHODS
|
US20140315881A1
(en)
*
|
2011-07-29 |
2014-10-23 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
WO2013029338A1
(en)
|
2011-09-01 |
2013-03-07 |
Glaxo Group Limited |
Novel compounds
|
WO2013042782A1
(ja)
|
2011-09-22 |
2013-03-28 |
武田薬品工業株式会社 |
縮合複素環化合物
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
WO2013067036A1
(en)
|
2011-10-31 |
2013-05-10 |
Rutgers, The State University Of New Jersey |
Direct inhibitors of keap1-nrf2 interaction as antioxidant inflammation modulators
|
WO2013064231A1
(en)
|
2011-10-31 |
2013-05-10 |
Phenex Pharmaceuticals Ag |
SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
|
US20140249196A1
(en)
|
2011-11-22 |
2014-09-04 |
Theodore Mark Kamenecka |
N-benzylbenzimidazole modulators of pparg
|
WO2013078240A1
(en)
|
2011-11-22 |
2013-05-30 |
Ripka Amy S |
N-biphenylmethylbenzimidazole modulators of pparg
|
WO2013079223A1
(en)
|
2011-12-02 |
2013-06-06 |
Phenex Pharmaceuticals Ag |
Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rorϒ, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases
|
US8741892B2
(en)
|
2011-12-05 |
2014-06-03 |
Boehringer Ingelheim International Gmbh |
Compounds
|
US8642774B2
(en)
|
2011-12-08 |
2014-02-04 |
Boehringer Ingelheim International Gmbh |
Compounds
|
US8796467B2
(en)
|
2011-12-13 |
2014-08-05 |
Boehringer Ingelheim International Gmbh |
Compounds
|
WO2013092460A1
(en)
|
2011-12-20 |
2013-06-27 |
Syngenta Participations Ag |
Cyclic bisoxime microbicides
|
US9567328B2
(en)
|
2011-12-21 |
2017-02-14 |
Allergan, Inc. |
Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
|
US20130190356A1
(en)
|
2011-12-22 |
2013-07-25 |
Genentech, Inc. |
Benzyl sulfonamide derivatives as rorc modulators
|
US9216988B2
(en)
|
2011-12-22 |
2015-12-22 |
Genentech, Inc. |
Benzyl sulfonamide derivatives as RORc modulators
|
WO2013100027A1
(ja)
|
2011-12-28 |
2013-07-04 |
武田薬品工業株式会社 |
複素環化合物
|
US9321750B2
(en)
|
2012-04-20 |
2016-04-26 |
Innov17 Llc |
ROR modulators and their uses
|
JP6182594B2
(ja)
|
2012-04-27 |
2017-08-16 |
グラクソ グループ リミテッドGlaxo Group Limited |
新規化合物
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
EP2844259A4
(en)
|
2012-04-30 |
2015-11-11 |
Anderson Gaweco |
MMR MODULATORS AND USES THEREOF
|
AU2013259624B2
(en)
|
2012-05-08 |
2017-10-19 |
Lycera Corporation |
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease
|
US9657033B2
(en)
|
2012-05-08 |
2017-05-23 |
Lycera Corporation |
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
|
CN104284657A
(zh)
|
2012-05-08 |
2015-01-14 |
默沙东公司 |
用于抑制RORγ活性和治疗疾病的双环砜化合物
|
JP6225178B2
(ja)
|
2012-05-31 |
2017-11-01 |
フェネックス ファーマシューティカルス アーゲー |
オーファン核内受容体RORγの調整剤としてのカルボキサミドまたはスルホンアミド置換されたチアゾールおよび関連する誘導体
|
WO2014008214A1
(en)
|
2012-07-02 |
2014-01-09 |
Biogen Idec Ma Inc. |
Biaryl-containing compounds as inverse agonists of ror-gamma receptors
|
AR092348A1
(es)
|
2012-07-11 |
2015-04-15 |
Hoffmann La Roche |
DERIVADOS DE ARIL-SULTAMO COMO MODULADORES DE RORc
|
WO2014026328A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof
|
WO2014026330A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
|
WO2014026329A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
|
WO2014028669A1
(en)
|
2012-08-15 |
2014-02-20 |
Biogen Idec Ma Inc. |
Novel compounds for modulation of ror-gamma activity
|
WO2014026327A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
|
US9156796B2
(en)
|
2012-09-21 |
2015-10-13 |
Sanofi |
Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators
|
US10035790B2
(en)
|
2012-10-19 |
2018-07-31 |
Exelixis, Inc. |
RORγ modulators
|
HUE033212T2
(hu)
|
2012-12-06 |
2017-11-28 |
Glaxo Group Ltd |
Retinoid-vonatkozású árva gamma receptorok (ROR-gamma) modulátorai, autoimmun és gyulladásos betegségek kezelésében való alkalmazásra
|
WO2013171729A2
(en)
|
2013-01-08 |
2013-11-21 |
Glenmark Pharmaceuticals S.A. |
Aryl and heteroaryl amide compounds as rorgamat modulator
|
CN105101970B
(zh)
|
2013-01-10 |
2018-11-20 |
维纳拓尔斯制药公司 |
β-内酰胺酶抑制剂
|
US9868748B2
(en)
|
2013-05-01 |
2018-01-16 |
Vitae Pharmaceuticals, Inc. |
Thiazolopyrrolidine inhibitors of ROR- γ
|
US9745297B2
(en)
|
2013-07-30 |
2017-08-29 |
Boehringer Ingelheim International Gmbh |
Compounds as modulators of RORC
|
WO2015035032A1
(en)
|
2013-09-05 |
2015-03-12 |
Boehringer Ingelheim International Gmbh |
Bicylic compounds as modulators of rorgamma
|
TWI652014B
(zh)
|
2013-09-13 |
2019-03-01 |
美商艾佛艾姆希公司 |
雜環取代之雙環唑殺蟲劑
|
CN105705492B
(zh)
|
2013-11-05 |
2019-11-05 |
豪夫迈·罗氏有限公司 |
作为rorc调节剂用于治疗自身免疫性疾病的5,6,7,8-四氢-5,8-亚甲基噌啉衍生物
|
WO2015083130A1
(en)
|
2013-12-06 |
2015-06-11 |
Aurigene Discovery Technologies Limited |
Fused pyridine and pyrimidine derivatives as ror gamma modulators
|
CN106103452B
(zh)
|
2013-12-24 |
2019-05-21 |
哈佛学院院长等 |
皮质抑素类似物及其合成和用途
|
JP2015124178A
(ja)
|
2013-12-26 |
2015-07-06 |
東レ株式会社 |
環状アミン誘導体及びその医薬用途
|
WO2015101928A1
(en)
|
2013-12-31 |
2015-07-09 |
Aurigene Discovery Technologies Limited |
Fused thiophene and thiazole derivatives as ror gamma modulators
|
US10407383B2
(en)
|
2014-02-03 |
2019-09-10 |
Basf Se |
Cyclopentene and cyclopentadiene compounds for controlling invertebrate pests
|
AU2015210833B2
(en)
*
|
2014-02-03 |
2019-01-03 |
Vitae Pharmaceuticals, Llc |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|
EA032357B1
(ru)
|
2014-03-26 |
2019-05-31 |
Ф. Хоффманн-Ля Рош Аг |
Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
|
CN106132935A
(zh)
|
2014-03-26 |
2016-11-16 |
巴斯夫欧洲公司 |
作为杀真菌剂的取代的[1,2,4]三唑和咪唑化合物
|
JO3512B1
(ar)
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
|
RS59477B1
(sr)
|
2014-03-26 |
2019-12-31 |
Hoffmann La Roche |
Biciklička jedinjenja kao inhibitori proizvodnje autotaksina (atx) i lizofosfatidne kiseline (lpa)
|
MX2016013518A
(es)
|
2014-04-16 |
2017-01-23 |
Glenmark Pharmaceuticals Sa |
Compuestos de aril y heteroaril eter como moduladores de ror gamma.
|
CN107074852B
(zh)
|
2014-10-14 |
2019-08-16 |
生命医药有限责任公司 |
ROR-γ的二氢吡咯并吡啶抑制剂
|
CN107206004A
(zh)
|
2014-10-22 |
2017-09-26 |
德克萨斯大学系统董事会 |
靶向盘状结构域受体1的小分子抑制剂及其用途
|
US9663515B2
(en)
|
2014-11-05 |
2017-05-30 |
Vitae Pharmaceuticals, Inc. |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|
CN112679467A
(zh)
|
2015-03-11 |
2021-04-20 |
Fmc公司 |
杂环取代的二环唑杀有害生物剂
|
EP3331876B1
(en)
|
2015-08-05 |
2020-10-07 |
Vitae Pharmaceuticals, LLC |
Modulators of ror-gamma
|
BR112018010018A2
(pt)
|
2015-11-20 |
2018-11-21 |
Vitae Pharmaceuticals Inc |
moduladores de ror-gama
|
TW202220968A
(zh)
|
2016-01-29 |
2022-06-01 |
美商維它藥物有限責任公司 |
ROR-γ調節劑
|
US9481674B1
(en)
|
2016-06-10 |
2016-11-01 |
Vitae Pharmaceuticals, Inc. |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|
AU2018307919B2
(en)
|
2017-07-24 |
2022-12-01 |
Vitae Pharmaceuticals, Llc |
Inhibitors of RORϒ
|
WO2019018975A1
(en)
|
2017-07-24 |
2019-01-31 |
Vitae Pharmaceuticals, Inc. |
INHIBITORS OF ROR GAMMA
|